Graham Capital Management, L.P. Acadia Pharmaceuticals Inc Transaction History

Graham Capital Management, L.P.

  • $3.11 Billion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024
BUY
$17.79 - $30.86 $247,423 - $429,200
13,908 Added 149.07%
23,238 $429,000
Q4 2023

Feb 14, 2024
BUY
$20.78 - $31.77 $193,877 - $296,414
9,330 New
9,330 $292,000
Q2 2022

Aug 15, 2022
SELL
$13.01 - $27.22 $226,035 - $472,920
-17,374 Closed
0 $0
Q1 2022

May 16, 2022
BUY
$20.94 - $27.5 $363,811 - $477,785
17,374 New
17,374 $420,000

Others Institutions Holding ACAD

# of Institutions
288
Shares Held
161M
Call Options Held
723K
Put Options Held
257K
View Full List

About ACADIA PHARMACEUTICALS INC

ACAD Quotes by TradingView
  • Ticker ACAD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 161,843,008
  • Market Cap $2.39B
  • Description
  • ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...
More about ACAD
Track This Portfolio

Track Graham Capital Management, L.P. Portfolio

Follow Graham Capital Management, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Graham Capital Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Graham Capital Management, L.P. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email